Leptin concentrations do not predict weight gain: The Mexico City Diabetes Study

International Journal of Obesity

Volumn 22, Issue 7, 1998, Pages 695-700

  Haffner, S M ^a   Mykkanen L A ^a   Gonzalez, C C ^b   Stern, M P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

Author keywords

Leptin; Weight change

Indexed keywords

LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD LEVEL; BODY FAT; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HORMONE SYNTHESIS; HUMAN; HUMAN EXPERIMENT; MALE; MEXICO; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0031837768     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800619     Document Type: Article

References (34)

1. Zhang Y, Proenca R, Maffei M, Barone M. Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995; 44: 855-858.
3. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1995; 1: 950-953.
4. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese MRNA expression in omental fat cells from massively obese humans. Nature Med 1995; 1: 953-956.
5. Caro JF, Sinha MK, Kolaczynski JW, Li Zhang P, Considine RV. Leptin: the role of an obesity gene. Diabetes 1996; 45: 1455-1462.
6. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. PNAS 1996; 93: 1726-1730.
7. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product or body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
8. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-2988.
9. Maffei M, Halaas, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1155-1161.
10. Considine RV, Sinha MK, Heiman ML, Kriauciiunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996; 334: 292-295.
11. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PK, Knowler W. Relatively low plasma leptin levels predict weight gain in Pima Indians. Nature Medicine 1997; 3: 238-240.
12. Stern MP, Gonzalez C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992; 41: 484-492.
13. Gonzalez C, Stern MP, Mitchell BD, Valdez R, Haffner SM, Perez BA. Clinical characteristics of type II diabetic subjects consuming high vs. low carbohydrate diets in Mexico City and San Antonio, TX. Diab Care 1994; 17: 397-404.
14. Haffner SM, Gonzalez C, Miettinen H, Kennedy E, Stern MP. A prospective analysis of the HOMA model. Diab Care 1996; 19: 1138-1141.
15. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK, Malina R. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes 1986; 10: 493-502.
16. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson J. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315: 220-224.
17. World Health Organization Study Group on Diabetes Mellitus. Report of a WHO Study Group. Tech. Rep. Ser. No. 727. World Health Organization: Geneva, 1985, pp 94-98.
18. Ma ZA, Gingerich RL, Santiago JV, Klein S, Smith HC, Landt M. Analyses of human plasma leptin by radioimmunoassay. Clin Chem 1996; 49: 942-946.
19. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RI. Leptin concentrations in diabetic and non-diabetic Mexican Americans. Diabetes 1996; 45: 822-824.
20. Neel JV. Diabetes Mellitus: A 'thrifty' genotype rendered detrimental by 'progress'. Am J Hum Genet 1962; 14: 353-362.
21. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Rax I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 86: 168-173.
22. Valdez R, Mitchell BD, Haffner SM, Hazuda HP, Morales PA, Monterrosa A, Stern MP. Predictors of weight gain in a biethnic population: the San Antonio Heart Study. Int J Obes 1994; 18: 85-91.
23. Haffner SM, Miettinen H, Mykkänen L, Karhapaa P, Rainwater D, Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes 1997; 21: 393-399.
24. Dagao-Jack S, Farelli C, Paramore D, Brothes J, Landt M. Plasma leptin and insulin relationships in obese and non-obese humans. Diabetes 1996; 45: 695-698.
25. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
26. Malmström R, Taskinen MR, Karonen SL, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
27. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin invest 1995; 95: 2986-2988.
28. Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E, Bogardus C, Ludwig DS, Flier JS, Talley M, Auerbach S, Friedman JM. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 1996; 45: 679-682.
29. Montague CT, Farooql IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
30. Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes 1996; 45: 691-694.
31. Clement K, Garner C, Hager J, Philippi A, LeDuc C, Carey A, Harris TJ, Jury C, Cardon LR, Basdevant A, Demenais F, Guy-Grand B, North M, Froguel P. Indication of linkage of the human OB gene region with extreme obesity. Diabetes 1996; 45: 687-690.
32. Norman RA, Leibel RL, Chung WK, Power-Kehoe L, Chua SC Jr, Knowler WC, Thompson DB, Bogardus C, Ravussin E. Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes 1996; 45: 1229-1232.
33. Stirling B, Cox NJ, Bell GI, Hanis CL, Spielman RS, Concannon P. Identification of microsatellite markers near the human OB gene and linkage studies in NIDDM-affected sib pairs. Diabetes 1995; 44: 999-1001.
34. Duggirala R, Stern MP, Mitchell BD, Reinhart LJ, Shipman PA, Uresandi OC, Chung WK, Leibel RL, Hales CN, O'Connell P, Blangero J. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 1996; 59: 694-703.